Evidence map›Paper›PMID 27527809›Full record

ReviewCytokine2018

Progranulin: A key player in autoimmune diseases.

Jinlong Jian, Guangfei Li, Aubryanna Hettinghouse, Chuanju Liu

Abstract readReview
In one paragraph

Review in Cytokine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Regulation of microglial activation by progranulin through the NF-κB pathway in subarachnoid hemorrhage and its effect on white matter injury.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review.International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Dementia, infections and vaccines: 30 years of controversy.Aging clinical and experimental research · 2023
    Review
  19. Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF.International journal of molecular sciences · 2023
    Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jinlong JianDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY 10003, United States.
Guangfei LiDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY 10003, United States; Department of Orthopedics, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China.
Aubryanna HettinghouseDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY 10003, United States.
Chuanju LiuDepartment of Orthopedics Surgery, New York University School of Medicine, New York, NY 10003, United States; Department of Cell Biology, New York University School of Medicine, New York, NY 10016, United States. Electronic address: chuanju.liu@nyumc.org.
New York University · USSoochow University · CN

Funding

The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1R01AR062207 · NIAMS · YALE UNIVERSITY · PI Chuanju Liu · 2012 to 2026
$5.6M
The Role of PGRN Growth Factor in Osteoarthritis. - Renewal - 1 - Revision - 2R01AR061484 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2011 to 2020
$4.8M
Progranulin Intervention in Inflammatory Bowel DiseasesR56AI100901 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LIU, CHUANJU · 2012 to 2013
$636k
NIAID NIH HHS R56 AI100901NIAMS NIH HHS R01 AR061484NIAMS NIH HHS R01 AR062207
6 · The paper itself

Abstract

Autoimmune disease encompasses an array of conditions with a variety of presentations and the involvement of multiple organs. Though the etiologies of many autoimmune conditions are unclear, uncontrolled inflammatory immune response is believed to be a major cause of disease development and progression. Progranulin (PGRN), an anti-inflammatory molecule with therapeutic effect in inflammatory arthritis, was identified as an endogenous antagonist of TNFα by competitively binding to TNFR. PGRN exerts its anti-inflammatory activity through multiple pathways, including induction of T

Indexed as

AnimalsArthritisAutoimmune DiseasesHumansInflammationInflammatory Bowel DiseasesIntercellular Signaling Peptides and ProteinsInterleukin-10MacrophagesMiceOsteoarthritisProgranulinsProtein BindingPsoriasisReceptors, Tumor Necrosis FactorSignal TransductionGRN protein, humanIntercellular Signaling Peptides and ProteinsInterleukin-10ProgranulinsReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaAutoimmune diseasesProgranulinTNFTNFR

Identifiers

PMID27527809
PMCPMC5303690
OpenAlexW2507406429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.